Headlines about Cerner (NASDAQ:CERN) have trended somewhat positive on Sunday, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cerner earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.2806576413362 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the headlines that may have effected Accern’s rankings:

A number of equities analysts have weighed in on the stock. Zacks Investment Research raised shares of Cerner from a “hold” rating to a “buy” rating and set a $78.00 target price for the company in a research note on Wednesday, January 31st. Stifel Nicolaus reaffirmed a “hold” rating and issued a $71.00 target price (up from $69.00) on shares of Cerner in a research note on Thursday, March 8th. BidaskClub raised shares of Cerner from a “strong sell” rating to a “sell” rating in a research note on Thursday, March 8th. Argus downgraded shares of Cerner from a “buy” rating to a “hold” rating and boosted their target price for the stock from $54.49 to $64.65 in a research note on Tuesday, March 13th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $80.00 target price on shares of Cerner in a research note on Monday, March 5th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $68.74.

Shares of CERN traded up $0.50 on Friday, reaching $59.94. 1,320,601 shares of the company’s stock were exchanged, compared to its average volume of 3,068,327. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.95 and a quick ratio of 2.93. The company has a market cap of $19.89 billion, a price-to-earnings ratio of 27.25, a price-to-earnings-growth ratio of 1.89 and a beta of 0.96. Cerner has a 12 month low of $52.05 and a 12 month high of $73.86.

Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Wednesday, May 2nd. The company reported $0.58 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.58. Cerner had a net margin of 16.50% and a return on equity of 15.80%. The business had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the previous year, the firm posted $0.59 earnings per share. Cerner’s revenue for the quarter was up 2.6% compared to the same quarter last year. analysts expect that Cerner will post 2.28 EPS for the current year.

In other Cerner news, Vice Chairman Clifford W. Illig sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $58.32, for a total value of $174,960.00. Following the completion of the sale, the insider now owns 1,229,719 shares of the company’s stock, valued at $71,717,212.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of the company’s stock in a transaction that occurred on Thursday, March 8th. The shares were sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the completion of the sale, the insider now directly owns 1,229,719 shares of the company’s stock, valued at approximately $79,341,469.88. The disclosure for this sale can be found here. Insiders sold 327,948 shares of company stock valued at $21,083,917 in the last ninety days. Insiders own 4.71% of the company’s stock.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Insider Buying and Selling by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.